ARCHIVES

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | April 26, 1974

Download PDF Visit The Full Archive

Related Articles

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

April 29, 2011

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

NCI, NIH Hoping 12 Percent Budget Cut Will Not Be Applied To Them

October 2, 1981

Lateral Radiation Therapy Results in Regional Control In Advanced Tonsil Cancer

February 28, 2014

U.S., France Offer Carcinogenesis Program

February 13, 1981